Events Calendar

Mon
Tue
Wed
Thu
Fri
Sat
Sun
M
T
W
T
F
S
S
30
12:00 AM - Hepatology 2021
31
1
2
3
4
7
8
9
10
11
13
14
15
16
18
19
20
21
22
23
24
25
27
28
29
30
1
2
World Nanotechnology Congress 2021
2021-03-29    
All Day
Nano Technology Congress 2021 provides you with a unique opportunity to meet up with peers from both academic circle and industries level belonging to Recent [...]
Nanomedicine and Nanomaterials 2021
2021-03-29    
All Day
NanoMed 2021 conference provides the best platform of networking and connectivity with scientist, YRF (Young Research Forum) & delegates who are active in the field [...]
Smart Materials and Nanotechnology
2021-03-29 - 2021-03-30    
All Day
Smart Material 2021 clears a stage to globalize the examination by introducing an exchange amongst ventures and scholarly associations and information exchange from research to [...]
Hepatology 2021
2021-03-30 - 2021-03-31    
All Day
Hepatology 2021 provides a great platform by gathering eminent professors, Researchers, Students and delegates to exchange new ideas. The conference will cover a wide range [...]
Annual Congress on  Dental Medicine and Orthodontics
2021-04-05 - 2021-04-06    
All Day
Dentistry Medicine 2021 is a perfect opportunity intended for International well-being Dental and Oral experts too. The conference welcomes members from every driving university, clinical [...]
World Climate Congress & Expo 2021
2021-04-06 - 2021-04-07    
All Day
Climatology is the study of the atmosphere and weather patterns over time. This field of science focuses on recording and analyzing weather patterns throughout the [...]
European Food Chemistry and Drug Safety Congress
2021-04-12 - 2021-04-13    
All Day
We invite you to meet us at the Food Chemistry Congress 2021, where we will ensure that you’ll have a worthwhile experience with scholars of [...]
Proteomics, Genomics & Bioinformatics
2021-04-12 - 2021-04-13    
All Day
Proteomics 2021 is one of the front platforms for disseminating latest research results and techniques in Proteomics Research, Mass spectrometry, Bioinformatics, Computational Biology, Biochemistry and [...]
Plant Science & Physiology
2021-04-17 - 2021-04-18    
All Day
The PLANT PHYSIOLOGY 2021 theme has broad interests, which address many aspects of Plant Biology, Plant Science, Plant Physiology, Plant Biotechnology, and Plant Pathology. Research [...]
Pollution Control & Sustainable 2021
2021-04-26 - 2021-04-27    
All Day
Pollution Control 2021 conference is organizing with the theme of “Accelerating Innovations for Environmental Sustainability” Conference Series llc LTD organizes environmental conferences series 1000+ Global [...]
Events on 2021-03-30
Hepatology 2021
30 Mar 21
Events on 2021-04-06
Events on 2021-04-17
Events on 2021-04-26
Articles

Columbia researchers develop kidney disease-spotting algorithm

chronic kidney disease

Columbia researchers develop kidney disease-spotting algorithm

As many as nine in 10 adults do not know they have chronic kidney disease, which can put them at risk for developing complications.

Researchers at Columbia University Vagelos College of Physicians and Surgeons have developed an algorithm that automatically scours electronic health records to alert physicians to early-stage chronic kidney disease.

The algorithm searches EHRs for results of blood and urine tests before performing calculations to indicate kidney function and damage and alerting clinicians.

“Identifying kidney disease early is of paramount importance, because we have treatments that can slow disease progression before the damage becomes irreversible,” said study leader Dr. Krzysztof Kiryluk, associate professor of medicine, in a statement to press.

More than one in seven adults is estimated to have chronic kidney disease, according to the U.S. Centers for Disease Control and Prevention, but as many as 90% don’t know they have it.

This can be a problem, as Kiryluk said, because early detection and treatment of CKD can prevent symptoms from worsening.

CKD is also more prevalent in Black and Latinx Americans than white Americans, making early detection an equity issue as well.

The reasons for under-diagnosis, notes the Columbia press release, are complex. Clinicians may not prioritize the necessary tests for diagnosis when it comes to asymptomatic patients, for example.

In addition, the interpretation for those necessary tests – one that measures a kidney-filtered metabolite in blood and another that measures leakage of protein in urine – can be challenging.

“Many patient characteristics, including age, sex, body mass or nutritional status, need to be considered, and this is frequently underappreciated by primary care physicians,” said Kiryluk.

Hence the Columbia algorithm, which was published in npj Digital Medicine earlier this month.

Researchers manually validated the algorithm with 451 chart reviews across three medical systems, and found that it diagnosed nephrologist-identified kidney disease correctly in 95% of patients, and ruled out kidney disease accurately in 97% of healthy patients.

“To assure transferability across different EHR systems, our algorithm was developed using training and validation datasets across several institutions,” according to the study.

The researchers proposed that the algorithmic diagnosis could enhance clinical care by enhancing patient and physician awareness of the disease and by enabling stage-specific recommendations for complication management.

“Although conceptually simple, our algorithm overcomes several important practical challenges stemming from real-life limitations of EHR data,” they wrote.

Despite kidney disease’s prevalence, technology to treat it has not meaningfully improved over the last few decades.

Public and private stakeholders are seeking to change that. The U.S. Department of Health and Human Services and the American Society of Nephrology have launched several prizes aimed at spurring kidney care innovation.

“Chronic kidney disease can cause multiple serious problems, including heart disease, anemia or bone disease, and can lead to an early death, but its early stages are frequently under-recognized and undertreated,” said Kiryluk.